EBMT 2020 | Outcomes of severe hepatic veno-occlusive disease after transplantation
Mohamad Mohty
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital and Sorbonne University, Paris, France, discusses the outcomes of severe hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
1:53 European regulation and access to advanced therapies
Aurélie Mahalatchimy
5:40 Gene editing: legal and ethical considerations
Aurélie Mahalatchimy
3:02 NK-CAR immunotherapy development over the past 12 months
Evelyn Ullrich
1:17 NK-CAR immunotherapy: the next steps
Evelyn Ullrich
3:06 Safety and outcome of prophylactic high-dose donor CD45RO+ memory T-cells after allo-HSCT
Mercedes Gasior Kabat
